You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Unknown Primary Squamous Cell Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer of Unknown Primary Site, Unknown Primary Cancer, Unknown Primary, Squamous Cell Carcinoma Trial in Copenhagen, Århus

Recruiting
  • Cancer of Unknown Primary Site
  • +2 more
  • Transoral Ultrasound
  • Copenhagen, Denmark
  • +1 more
May 2, 2023

Head Neck Cancer, Unknown Primary Cancer, Head and Neck Squamous Cell Carcinoma Trial in Dallas (Pegsitacianine)

Not yet recruiting
  • Head and Neck Cancer
  • +2 more
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Jan 18, 2023

Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma, Unknown Primary Trial in Liverpool (Versius Surgical System)

Not yet recruiting
  • Squamous Cell Carcinoma of the Oropharynx
  • Squamous Cell Carcinoma, Unknown Primary
  • Versius Surgical System
  • Liverpool, United Kingdom
    Liverpool Head and Neck Centre, ENT Department Liverpool Univers
Oct 27, 2023

Head and Neck Carcinoma of Unknown Primary, Locally Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Laryngeal

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +5 more
  • External Beam Radiation Therapy
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 1, 2022

Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the

Recruiting
  • Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • +2 more
  • Atezolizumab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jan 19, 2022

Circulating Biomarkers in Oropharyngeal Cancers

Active, not recruiting
  • Oropharynx Squamous Cell Carcinoma
  • +3 more
    • Orebro, Sweden
      Anna Oldaeus Almerén
    Jun 13, 2023

    Analgesia, Surgery, Cancer of Head and Neck Trial in Copenhagen (Dexamethasone, Placebo)

    Active, not recruiting
    • Analgesia
    • +6 more
    • Copenhagen, Denmark
      Department of Otorhinolaryngology, Head and Neck Surgery & Audio
    Oct 14, 2022

    Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

    Recruiting
    • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
    • +24 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    May 18, 2022

    Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma in Cervical Lymph Node Trial in Houston

    Active, not recruiting
    • Metastatic Head and Neck Squamous Cell Carcinoma
    • Metastatic Squamous Cell Carcinoma in Cervical Lymph Node
    • Computed Tomography
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 1, 2022

    Solid Tumor, Breast Cancer, Small Cell and NSCLC Trial in Hackensack (RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior

    Recruiting
    • Solid Tumor
    • +15 more
    • RAPA-201 Rapamycin Resistant T Cells
    • Chemotherapy Prior to RAPA-201 Therapy
    • Hackensack, New Jersey
      Hackensack University Medical Center
    Dec 23, 2021

    Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

    Recruiting
    • Head and Neck Carcinoma of Unknown Primary
    • +5 more
    • Atlanta, Georgia
      Emory University/Winship Cancer Institute
    Feb 17, 2022

    Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell

    Active, not recruiting
    • Head and Neck Carcinoma of Unknown Primary
    • +19 more
    • Duarte, California
    • +18 more
    Aug 24, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Toronto (da Vinci Surgical System Model IS4000)

    Active, not recruiting
    • Head and Neck Squamous Cell Carcinoma
    • da Vinci Surgical System Model IS4000
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 16, 2021

    MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

    Active, not recruiting
    • MSI-H Colorectal Cancer
    • +30 more
    • Badalona, Barcelona, Spain
    • +9 more
    Oct 24, 2022

    Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

    Recruiting
    • Head and Neck Carcinoma of Unknown Primary
    • +24 more
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Aug 6, 2022

    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

    Completed
    Has Results
    • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
    • +35 more
    • PI3K inhibitor BKM120
    • cetuximab
    • Chicago, Illinois
      University of Chicago Comprehensive Cancer Center
    Sep 14, 2021

    Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell

    Active, not recruiting
    • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
    • +29 more
    • Cytology specimen
    • Laboratory biomarker analysis
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Aug 31, 2021

    Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

    Recruiting
    • Adenoid Cystic Skin Carcinoma
    • +38 more
    • Biopsy
    • +6 more
    • Los Angeles, California
    • +35 more
    Jan 31, 2023

    Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])

    Not yet recruiting
    • Neoplasms
    • +2 more
    • Nivolumab Injection [Opdivo]
    • (no location specified)
    Jul 19, 2023

    Head Neck Cancer Trial (IMRT)

    Completed
    • Head and Neck Cancer
    • IMRT
    • (no location specified)
    Sep 3, 2020

    Oral Squamous Cell Carcinoma Trial in Beijing (Toripalimab)

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • Beijing, China
      Peking Union Medical College Hospital, Chinese Academy of Medica
    Apr 5, 2023

    HLA-DR in Cell Cultures Isolated From Primary Squamous Cell

    Active, not recruiting
    • Squamous Cell Carcinoma of the Head and Neck
    • Cancer
    • cell culture
    • Roma, Lazio, Italy
      Fondazione Policlinico Universitario Gemelli, Irccs
    Sep 11, 2023

    Esophageal Squamous Cell Carcinoma Trial in Shanghai (Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2),Immunotherapy

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2)，Immunotherapy (camrelizumab 200mg)、Radiotherapy(primary lesion and adjacent lymph nodes 41.4Gy， distant lymph node 0.5Gy*4)
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Dec 6, 2022

    Esophageal Squamous Cell Carcinoma in Malawi

    Completed
    • Esophageal Squamous Cell Carcinoma
      • Lilongwe, Malawi
      • +1 more
      Jan 5, 2023

      Squamous Cell Carcinoma, Nonmelanoma Skin Cancer, Cutaneous Squamous Cell Carcinoma Trial in Indianapolis (sentinel lymph node

      Recruiting
      • Squamous Cell Carcinoma
      • +2 more
      • sentinel lymph node biopsy (SLNB)
      • Indianapolis, Indiana
        Indiana University Melvin & Bren Simon Cancer Center
      Nov 15, 2022